GIPZ Lentiviral shRNA

microRNA-adapted shRNA based on miR-30 for specific gene silencing with minimal cytotoxicity


Perform specific and efficient, transient or long-term RNAi with GIPZ Lentiviral shRNA. GIPZ Lentiviral shRNA targets human and mouse genes using multiple shRNA constructs that have been cloned into the pGIPZ lentiviral vector.
Enter a common gene identifier and click SEARCH to find products for your gene

Common gene identifiers for your gene can be found at NCBI Gene or miRBase.

IdentifierDescriptionExamples
Gene IDThe Gene ID is a unique identifying number for each gene in the RefSeq database and tends to be the most stable gene identifier.
  • 672
  • 22421
Accession NumberAccession Numbers are identifiers for a sequence record. The preferred accession numbers for RNAi products are found in the Reference Sequence (RefSeq) database, a non-redundant, curated, and annotated collection of sequence records for major model organisms. RefSeq accession numbers for mRNA begin with the characters NM_ or XM_ followed by six or nine digits. For gene expression products, the GenBank accession number for the clone can also be used for more specific search results.
  • NM_001798
  • NM_001170537
  • BC068303
Gene SymbolThe Gene Symbol can be the official or alternate symbol as displayed on NCBI Gene.
  • BRCA1
  • CDK1
  • CTNNB1
Gene DescriptionThe Gene Description is also known as the Official Full Name on NCBI Gene.
  • myogenic differentiation 1
  • thyroid peroxidase
  • breast cancer 1, early onset
miRBase IdentifiersmiRBase accession numbers are the most stable identifiers for microRNA. The miRBase ID, or name, may also be used.
  • miRBase ID: hsa-let-7d, mmu-mir-122
  • Precurser Accession: MI0000065, MI0000256
  • Mature Accession: MIMAT0000065, MIMAT0000246

If you require further assistance with your search, please contact Technical Support at ts.dharmacon@ge.com

powered by Ingenuity
ProductCatalog Number 
GIPZ Mouse Lentiviral shRNA Individual Clone
VGM5520 2 x 25 µl viral particles - $780.00select
GIPZ shRNA Viral Particle Starter Kit
VGH5526 viral particles set - $1,034.00select
GIPZ Human Lentiviral shRNA Individual Clone
VGH5518 2 x 25 µl viral particles - $780.00select
GIPZ Human Lentiviral shRNA Clone Gene Set
RHS4531 1 each - $430.00select
GIPZ Mouse Lentiviral shRNA Clone Gene Set
RMM4532 glycerol set - $430.00select
GIPZ Lentiviral shRNA Transduction Starter Kit
RHS5086 glycerol kit - $1,354.00select
GIPZ Human Lentiviral shRNA Transfection Starter Kit
RHS4287 glycerol kit - $900.00select
The GIPZ microRNA-adapted shRNA collection was developed in collaboration with Gregory Hannon and Steve Elledge at Cold Spring Harbor Laboratories (CSHL). GIPZ shRNA designs are based on native miR-30 primary transcript to enable processing by the endogenous RNAi pathway and result in specific gene silencing with minimized cellular toxicity.

Highlights

  • microRNA-adapted shRNA for specific knockdown
  • TurboGFP marks cells expressing shRNA
  • Genome-wide human and mouse representation
  • Lentiviral delivery extends RNAi to primary and non-dividing cells
  • Generation and maintenance of stable cell lines facilitated by puromycin selection marker

Pre-designed human and mouse GIPZ shRNA designs are available as bacterial glycerol stocks or high-titer lentiviral particles. Search for your gene(s) of interest to find

  • Individual shRNA constructs, supplied as E. coli glycerol stocks or high-titer lentiviral particles (1x108 TU/mL, ± 20%, functional titer obtained by flow cytometric analysis of transduced GFP-positive HEK293T cells)
  • shRNA Starter Kits which include positive and negative controls, plus delivery reagent
  • Target Gene Sets comprised of 3 to 6 GIPZ shRNA constructs

*One out of three GIPZ Lentiviral shRNA is guaranteed to produce gene knockdown by ≥ 70% at the mRNA level when used in shRNA Starter Kit. Knockdown should be compared to non-silencing control and experimental workflow must be controlled using the provided GIPZ GAPDH positive control.

GIPZ Lentiviral shRNA Starter Kits
The GIPZ Lentiviral shRNA Starter Kits combine the versatility of lentiviral shRNA, the convenience of experimental controls and the necessary mode of delivery for RNAi experimentation.

  • Your choice of GIPZ lentiviral shRNA constructs targeting human or mouse genes
  • Positive and negative GIPZ lentiviral shRNA controls
  • Kits for delivery of GIPZ shRNA by transfection or transduction
  • Guaranteed knockdown when at least 3 GIPZ shRNAs are tested following protocols and using the included GIPZ shRNA positive and negative controls

The GIPZ Transduction Starter Kit  includes:

  • Three GIPZ shRNA as E. coli glycerol stock cultures
  • Trans-Lentiviral packaging mix sufficient for 10 packaging events
  • Calcium phosphate transfection reagent
  • Positive and negative GIPZ lentiviral shRNA controls‡
  • Guaranteed knockdown† when at least 3 GIPZ shRNAs are tested following protocols and using the included GIPZ shRNA positive and negative controls

The GIPZ Transfection Starter Kit includes:

  • Three GIPZ shRNA as E. coli glycerol stock cultures
  • Positive and negative GIPZ lentiviral shRNA controls‡
  • TurboFect transfection reagent for delivery of shRNA plasmid
  • Guaranteed knockdown† when at least 3 GIPZ shRNAs are tested following protocols and using the included GIPZ shRNA positive and negative controls

Transduction-ready high-titer lentiviral particle format reduces time, labor, and costs involved in prepping DNA, packaging and purifying lentiviral particles for your RNAi experiments. Concentrated, high-titer lentiviral particles allow multiple experiments in a variety of cell types requiring variable multiplicity of infection (MOI). Lentiviral particles are provided at titers of 1x108 TU/mL, ± 20%, functional titer obtained by flow cytometric analysis of transduced GFP-positive HEK293T cells).

***Please note that due to the inherent complexity of high-titer lentiviral particle production, we estimate a 6 to 8 week turnaround time.

† When you purchase a minimum of three shRNA to the same target, at least one of the shRNA constructs will reduce target mRNA levels by 70% or more when used with Starter Kit protocols and normalized for transfection efficiency. Transfection conditions should be confirmed using appropriate positive controls provided in the kit and the percent-knockdown should be compared to cells transfected with the negative control (non-targeting) shRNA.

‡ For a list of positive controls included in each Starter Kit, please see the relevant specification sheet.

Please note that the GIPZ Lentiviral shRNA and TRIPZ Inducible Lentiviral shRNA are not compatible with third generation packaging systems, such as ViraPower from Invitrogen. We recommend the Trans-Lentiviral Packaging System to general lentiviral particles for transduction of GIPZ and TRIPZ shRNA.

  
HazardousNo
Shelf Life12 Months
Shipping ConditionDry Ice,Wet Ice
Storage Condition-80 C
pGIPZ vector elements

pGIPZ vector elements

pGIPZ vector elements

Figure 1.


Effective knockdown using GIPZ lentiviral shRNA

Effective knockdown using GIPZ lentiviral shRNA

Effective knockdown using GIPZ lentiviral shRNA

Figure 2. OVCAR-8 cells were transduced with GIPZ lentiviral shRNA constructs at MOI = 0.4 to2 in 2 to 4 biological replicates. Cells were puromycin-selected (30 μg/mL) starting 48 hours post-transduction. RNA was isolated 84 hours posttransduction.

qPCR was performed in triplicate via TaqMan® Gene Expression Assays using 18S rRNA as an internal reference. On average, two out of three shRNA produced greater than 70% knockdown compared to the GIPZ Non-targeting Control shRNA.


Knockdown efficiency of GIPZ lentiviral shRNA

Knockdown efficiency of GIPZ lentiviral shRNA

Knockdown efficiency of GIPZ lentiviral shRNA

Figure 3. HEK293T cells were transduced with lentiviral particles containing shRNA to GAPDH, eG5, p53, Rb, or STAT6. Non-silencing shRNA was transduced as a control. The graph depicts the residual levels of these genes normalized to their equivalent non-silencing control.


TurboGFP expression in transduced cells

TurboGFP expression in transduced cells

TurboGFP expression in transduced cells

Figure 4. TurboGFP expression from the pGIPZ vector allows measurment of transfection and transduction efficiency. It also effectively marks shRNA expression in target cells. (A) HEK293 cells 48 hrs post-transduction and (B) the corresponding phase image.


References

Citations